Press release
Autoimmune Uveitis Patient Pool Expected to Expand at a CAGR of 5.7%
Autoimmune Uveitis Market
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72309
Introduction
Autoimmune uveitis refers to intraocular inflammation caused by systemic autoimmune or autoinflammatory disorders. It is a leading cause of preventable vision loss among working-age adults. Although often underdiagnosed, increasing access to ophthalmic imaging tools-such as OCT, fluorescein angiography, and fundus photography-has significantly improved early detection.
Specialist referral pathways between rheumatology and ophthalmology clinics are strengthening disease recognition, while biologic therapies, corticosteroid implants, and immunomodulatory agents are increasingly used to manage chronic autoimmune uveitis.
Key Takeaways
• The Autoimmune Uveitis Patient Pool is projected to grow at a CAGR of 5.7% through the forecast period.
• Increased identification of systemic autoimmune diseases is expanding the uveitis patient base.
• Technological advancements such as OCT, OCT-A, wide-field imaging, and AI-enabled retinal screening improve case detection.
• Leading therapy classes include corticosteroids, immunosuppressants, and anti-TNF/biologic agents.
• Key stakeholders include ophthalmology clinics, rheumatology centers, diagnostic labs, and pharmaceutical developers.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72309/autoimmune-uveitis-patient-pool-analysis-market
Market Drivers
• Rising prevalence of autoimmune disorders: Ankylosing spondylitis, Behçet's disease, psoriasis, lupus, and IBD remain high-risk groups for uveitis.
• Improved diagnostic access: Widespread adoption of OCT, fundus photography, and fluorescein angiography strengthens early detection.
• Growing awareness among clinicians: Stronger collaboration between rheumatologists and ophthalmologists enhances patient referral rates.
• Increased adoption of biologic therapies: Anti-TNF and other targeted agents are improving long-term disease control.
• Government blindness-prevention programs: Encouraging timely screening and treatment in high-risk populations.
Market Segmentation
By Disease Type
• Anterior Uveitis
• Intermediate Uveitis
• Posterior Uveitis
• Panuveitis
By Associated Autoimmune Condition
• Ankylosing Spondylitis
• Behçet's Disease
• Psoriatic Arthritis
• Sarcoidosis
• Multiple Sclerosis
• Rheumatoid Arthritis
• Inflammatory Bowel Disease (Crohn's, Ulcerative Colitis)
• Juvenile Idiopathic Arthritis (JIA)
• Others
By Diagnostic Technology
• Fundus Examination
• Optical Coherence Tomography (OCT & OCT-A)
• Fluorescein Angiography
• Indocyanine Green (ICG) Angiography
• Ultrasound B-scan
• AI-Based Screening Tools
By End User
• Hospitals
• Ophthalmology Clinics
• Specialty Rheumatology/Ophthalmology Centers
• Diagnostic Laboratories
• Research Institutes
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72309
Regional Outlook
North America
Leads the market due to advanced imaging technologies, strong autoimmune disease awareness, and widespread access to biologic therapies.
Europe
High prevalence of autoimmune disorders and strong interdisciplinary care networks support significant patient pool expansion.
Asia-Pacific
Fastest-growing region due to increasing autoimmune disease diagnosis, rising diabetic and infectious triggers, and improving ophthalmology infrastructure in India, China, and Southeast Asia.
Latin America & Middle East/Africa
Growing adoption driven by expanding healthcare access and increased ophthalmology screening programs, though diagnosis remains lower than global averages.
Recent Developments
• Introduction of new biologic agents targeting TNF-α, IL-6, and JAK pathways for severe autoimmune uveitis.
• Expansion of sustained-release corticosteroid implants improving long-term inflammation control.
• Growing use of wide-field retinal imaging for earlier detection of posterior and panuveitis.
• AI-enabled uveitis diagnostic platforms under development for remote and early screening.
• Increased clinical research collaborations between ophthalmology and immunology institutes.
Expert Quote
"Autoimmune uveitis is an increasingly recognized cause of vision impairment among younger and middle-aged adults. With advancements in imaging, biologics, and interdisciplinary care, early diagnosis and effective treatment are becoming far more achievable,"
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Future Outlook
The Autoimmune Uveitis Patient Pool is expected to expand steadily as autoimmune disease identification improves and new diagnostic and therapeutic innovations enter the market. The next decade will see growing use of AI-powered tools, personalized immunotherapy, and long-acting ocular drug delivery systems.
This report is also available in the following languages : Japanese (自己免疫性ぶどう膜炎市場), Korean (자가면역성 포도막염 시장), Chinese (自身免疫性葡萄膜炎市场), French (Marché de l'uvéite auto-immune), German (Markt für Autoimmun-Uveitis), and Italian (Mercato dell'uveite autoimmune), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72309
Our More Reports:
Diabetic Peripheral Neuropathy Market
https://exactitudeconsultancy.com/reports/71902/diabetic-peripheral-neuropathy-market
Fibromyalgia Market
https://exactitudeconsultancy.com/reports/71904/fibromyalgia-market
Hypothalamic Obesity Market
https://exactitudeconsultancy.com/reports/71906/hypothalamic-obesity-market
Leigh Syndrome Market
https://exactitudeconsultancy.com/reports/71908/leigh-syndrome-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autoimmune Uveitis Patient Pool Expected to Expand at a CAGR of 5.7% here
News-ID: 4305338 • Views: …
More Releases from Exactitude Consultancy
Bullous Keratopathy Market to Grow at a CAGR of 5.4%
Pune, India - Exactitude Consultancy: The global Bullous Keratopathy Market is projected to grow at a CAGR of 5.4% during the forecast period. Rising cases of corneal endothelial diseases, complications from cataract surgery, and improved access to corneal transplantation are major contributors to market growth. Advancements in endothelial keratoplasty and emerging regenerative therapies are reshaping the treatment landscape.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72223
Introduction
Bullous keratopathy results from damage…
Age-Related Vision Dysfunction Market Set to Grow at a CAGR of 6.5%
Pune, India - Exactitude Consultancy: The global Age-Related Vision Dysfunction Market is projected to grow at a CAGR of 6.5% over the forecast period. Rising life expectancy, expanding aging demographics, and increasing diagnosis of ophthalmic disorders such as cataracts, AMD, glaucoma, and diabetic retinopathy are driving overall market expansion. Technological advancements in diagnostic imaging, surgical equipment, and vision correction therapies continue to strengthen market adoption.
Download Full PDF Sample Copy of…
Age-Related Macular Degeneration (AMD) Market to Grow at a CAGR of 7.1%
Pune, India - Exactitude Consultancy: The global Age-Related Macular Degeneration (AMD) Market is projected to grow at a CAGR of 7.1% over the forecast period. Growth is fueled by rising aging populations, increased case detection through advanced imaging tools, and expanding access to anti-VEGF injections, combination therapies, and emerging gene and cell-based treatments.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72217
Introduction
Age-related macular degeneration (AMD) is the leading cause of irreversible…
Neuromodulation Devices Market to Grow at a CAGR of 10.2%
Pune, India - Exactitude Consultancy: The global Neuromodulation Devices Market is projected to grow at a strong CAGR of 10.2% over the forecast period. Rising prevalence of chronic pain, movement disorders, epilepsy, depression, and other neurological conditions is significantly increasing demand for advanced neuromodulation therapies. Technological advancements-including closed-loop systems, miniaturized implants, wireless charging, and AI-enabled stimulation algorithms-are transforming patient outcomes and driving mass adoption.
Download Full PDF Sample Copy of Market…
More Releases for Uveitis
Uveitis Market : An Overview Report
Introduction:
Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis…
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of…
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based…
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview
Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures.
Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html
As per Cochrane,…
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &…
